One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
ﻗﯿﻤﺖ : 300$- ﻗﯿﻤﺖ ﻭﯾﮋﻩ : 100$
The immune awakening: Transformative strategies against brain tumors
Association of symptoms of neuropsychological long COVID with imaging and plasma biomarkers
Profiling mitochondrial DNA indices across whole blood, plasma, and CSF in amyotrophic lateral sclerosis
Association of biological age markers with stroke prevalence: Insights from a cross-sectional study
Workshop report: Findings from the 2025 Italian SMAkers Educational Initiative on SMA management in Italy
Climate change and brain health, a risk management approach focusing on the European region: A narrative review
Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived features
Cerebrospinal fluid HOMER1 and NPTX2 as candidate signatures in early-stage multiple system atrophy-parkinsonism
Clinical implications of progressive ventilatory impairment in multiple system atrophy and progressive supranuclear palsy
Response to letter to the editor “Comment on: Clinical safety of ultra-high-dose methylcobalamin in patients with amyotrophic lateral sclerosis: Open-label extension of a phase 2/3 randomized controlled study”
Reply to the Letter to the Editor regarding “Clinical implications of progressive ventilatory impairment in multiple system atrophy and progressive supranuclear palsy”
Ultra-high-dose methylcobalamin demonstrates safety in advanced ALS, but intramuscular administration poses practical burdens and its selected study cohort limits generalizability
Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al.
Reply: Pathophysiological, methodological, and statistical considerations in CGRP monoclonal antibody therapy: A comment on Imai et al
Response to the letter by Yang and Xia: Clarifying the clinical and methodological boundaries of plasma and salivary p-Tau181 in Alzheimer's disease
Letter to the editor: Impact of corticosteroid use on comorbidities in patients with myasthenia gravis in the US National Veterans Affairs Health Network
Clarifying the clinical and methodological boundaries of plasma and salivary p-Tau181 in Alzheimer's disease
Distinguishing pharmacological toxicity from disease severity and lifestyle confounders in myasthenia gravis comorbidity models
Authors' response to reviewers' comments on “Effectiveness and safety of prasugrel- versus clopidogrel-based dual antiplatelet therapy for acute ischemic stroke”
Letter to the editor: Effectiveness and safety of prasugrel- versus clopidogrel-based dual antiplatelet therapy for acute ischemic stroke
Long term safety and efficacy of vigabatrin in Lennox-Gastuat syndrome: a long way to go
Comment on “Safety and efficacy of vigabatrin add on compared to placebo in Lennox-Gastaut syndrome (LennoVig): A single center randomized double-blind placebo-controlled trial”
Letter to the editor: The impact of adding optical coherence tomography in MS diagnostic criteria on the classification of Tumefactive demyelination
Commentary on “Impact of early cognitive and psychological status on return to work after acute ischemic stroke”
Response to commentary on “Impact of early cognitive and psychological status on return to work after acute ischemic stroke”
Comment on “Plasma neurofilament light chain to evaluate response during cladribine treatment in multiple sclerosis”
